Kiora Pharmaceuticals (KPRX) Insider Trading & Ownership $3.32 +0.04 (+1.22%) Closing price 03:54 PM EasternExtended Trading$3.20 -0.12 (-3.61%) As of 07:35 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Kiora Pharmaceuticals (NASDAQ:KPRX) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage0.94%Number OfInsiders Buying(Last 12 Months)6Amount OfInsider Buying(Last 12 Months)$64,388.79Number OfInsiders Selling(Last 12 Months)0 Get KPRX Insider Trade Alerts Want to know when executives and insiders are buying or selling Kiora Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address KPRX Insider Buying and Selling by Quarter Kiora Pharmaceuticals Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails9/10/2024Aron ShapiroDirectorBuy3,000$3.60$10,800.00 8/19/2024Lisa Walters-HoffertDirectorBuy1,250$3.86$4,825.00 6/14/2024Eric Joseph DanielsInsiderBuy1,431$5.29$7,569.99 6/14/2024Melissa ToscaEVPBuy100$5.25$525.00 6/13/2024Brian M StremCEOBuy3,000$5.00$15,000.00 6/13/2024Erin ParsonsDirectorBuy5,260$4.88$25,668.80 (Data available from 1/1/2013 forward) KPRX Insider Trading Activity - Frequently Asked Questions Who is on Kiora Pharmaceuticals's Insider Roster? The list of insiders at Kiora Pharmaceuticals includes Aron Shapiro, Brian M Strem, Eric Joseph Daniels, Erin Parsons, Lisa Walters-Hoffert, and Melissa Tosca. Learn more on insiders at KPRX. What percentage of Kiora Pharmaceuticals stock is owned by insiders? 0.94% of Kiora Pharmaceuticals stock is owned by insiders. Learn more on KPRX's insider holdings. Which Kiora Pharmaceuticals insiders have been buying company stock? The following insiders have purchased KPRX shares in the last 24 months: Aron Shapiro ($10,800.00), Brian M Strem ($15,000.00), Eric Joseph Daniels ($7,569.99), Erin Parsons ($25,668.80), Lisa Walters-Hoffert ($4,825.00), and Melissa Tosca ($525.00). How much insider buying is happening at Kiora Pharmaceuticals? Insiders have purchased a total of 14,041 KPRX shares in the last 24 months for a total of $64,388.79 bought. Kiora Pharmaceuticals Key ExecutivesDr. Brian M. Strem Ph.D. (Age 44)President, CEO & Director Compensation: $464.93kDr. Eric J. Daniels M.B.A. (Age 50)M.D., Chief Development Officer Compensation: $371.47kDr. Stefan Sperl Ph.D.Executive Vice President of CMC & Operations More Insider Trading Tools from MarketBeat Related Companies Opus Genetics Insider Buying Lantern Pharma Insider Buying X4 Pharmaceuticals Insider Buying Scilex Insider Buying OS Therapies Insider Buying NRx Pharmaceuticals Insider Buying Surrozen Insider Buying Cadrenal Therapeutics Insider Buying Pluri Insider Buying Marinus Pharmaceuticals Insider Buying Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles McDonald’s Insiders Sell Shares! Investors Should Do the Opposite5 Mid-Cap Stocks Insiders Are Buying This YearInsider Buying in This Stock Reiterates Analysts Bullish OutlookBeware of BigBear.ai: Insiders Are Selling—Should You?XPO Buying $50 Million of Its Own Stock: Here's Why This page (NASDAQ:KPRX) was last updated on 5/2/2025 by MarketBeat.com Staff From Our PartnersElon’s Terrifying Warning Forces Trump To Take ActionElon Musk has avoided two major financial crises before. He pulled Tesla and SpaceX back from the brink of col...American Hartford Gold | SponsoredSecret financial plot unfolding in Washington DC… [DEVELOPING]What stocks are next up to soar in 2025? I believe I’ve found the answer - and it might surprise you. Yo...Timothy Sykes | SponsoredTrump Orders 'National Digital Asset Stockpile'Billionaires Rush Into Digital Banking Token Three massive forces are converging right now, creating what c...Crypto 101 Media | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredHere’s How to Claim Your Stake in Elon’s Private Company, xAII predict this single breakthrough could make Elon the world’s first trillionaire — and mint more new milliona...Brownstone Research | SponsoredBuffett’s favorite chart just hit 209% – here’s what that means for goldA Historic Gold Announcement Is About to Rock Wall Street For months, sharp-eyed analysts have watched the ...Golden Portfolio | SponsoredWarning: “DOGE Collapse” imminentElon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week...Altimetry | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Kiora Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Kiora Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
